NCT06366581

Brief Summary

This study included patients who underwent surgical treatment for incisional hernia and non-hernia conditions. Surgical specimens were collected for transcriptome sequencing to obtain the gene expression list. Then genes analyzed by Gene Ontology, protein interactions, and signaling pathway enrichment using the expression matrix.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

March 7, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 16, 2024

Completed
Last Updated

April 16, 2024

Status Verified

March 1, 2024

Enrollment Period

6 months

First QC Date

March 7, 2024

Last Update Submit

April 14, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • the gene expression list

    the gene expression list

    2023.3-2023.9

Study Arms (2)

IH group

Patients who underwent incisional hernia repair were defined as the experimental group (labelled as the IH group)

Diagnostic Test: Transcriptomic analysis

NC group

patients who underwent laparoscopic cholecystectomy were defined as the control group (labelled as the NC group)

Diagnostic Test: Transcriptomic analysis

Interventions

high-throughput sequencing technology

IH groupNC group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who underwent incisional hernia repair were defined as the experimental group (labelled as the IH group), and patients who underwent laparoscopic cholecystectomy were defined as the control group (labelled as the NC group).

You may qualify if:

  • to 75 years 2.diagnosed with incisional hernia 3.normal tumour markers 4.elective surgery patients.

You may not qualify if:

  • patients with vital organ failure (heart liver, lung, kidney and others)
  • malignant tumors not been completely relieved by active treatment,
  • patients who have psychiatric diseases or comprehension disorders.
  • patients with metabolic disease involving connective tissue collagen.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hua Dong Hospital Affiliated to Fu Dan University

Shanghai, China

Location

MeSH Terms

Conditions

Incisional Hernia

Condition Hierarchy (Ancestors)

HerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic Processes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

March 7, 2024

First Posted

April 16, 2024

Study Start

March 1, 2023

Primary Completion

September 1, 2023

Study Completion

March 1, 2024

Last Updated

April 16, 2024

Record last verified: 2024-03

Locations